Holen Sie sich die Stockscreener-App
3.315
9.92%
-0.365
Handel nachbörslich:
3.32
0.005
+0.15%
Schlusskurs vom Vortag:
$3.68
Offen:
$3.73
24-Stunden-Volumen:
351.04K
Relative Volume:
0.88
Marktkapitalisierung:
$138.49M
Einnahmen:
$68.68M
Nettoeinkommen (Verlust:
$-60.84M
KGV:
-2.0719
EPS:
-1.6
Netto-Cashflow:
$-38.42M
1W Leistung:
-3.63%
1M Leistung:
-36.86%
6M Leistung:
-50.67%
1J Leistung:
-62.20%
1-Tages-Spanne:
$3.31
$3.76
1-Wochen-Bereich:
$3.31
$3.7908
52-Wochen-Spanne:
$3.31
$9.405
Pulmonx Corp Stock (LUNG) Company Profile
Firmenname
Pulmonx Corp
Sektor
Branche
Telefon
650-364-0400
Adresse
700 CHESAPEAKE DRIVE, REDWOOD CITY
Vergleichen Sie LUNG mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LUNG
Pulmonx Corp
|
3.315 | 138.49M | 68.68M | -60.84M | -38.42M | -1.60 |
|
ABT
Abbott Laboratories
|
129.05 | 231.50B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.95 | 154.04B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
387.53 | 144.27B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
85.11 | 105.58B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
75.50 | 43.95B | 5.54B | 4.18B | 623.10M | 7.00 |
Pulmonx Corp Stock (LUNG) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-10 | Eingeleitet | D. Boral Capital | Buy |
| 2024-12-11 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-06-04 | Eingeleitet | Lake Street | Buy |
| 2024-02-23 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-09-05 | Eingeleitet | Craig Hallum | Buy |
| 2023-02-27 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-01-03 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-12-12 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-07-11 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-03-02 | Fortgesetzt | BofA Securities | Neutral |
| 2021-12-08 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2021-04-01 | Eingeleitet | Citigroup | Buy |
| 2021-03-25 | Eingeleitet | Piper Sandler | Neutral |
| 2021-03-10 | Hochstufung | BofA Securities | Neutral → Buy |
| 2021-01-04 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-10-26 | Eingeleitet | BofA Securities | Buy |
| 2020-10-26 | Eingeleitet | Canaccord Genuity | Buy |
| 2020-10-26 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2020-10-26 | Eingeleitet | Stifel | Buy |
| 2020-10-26 | Eingeleitet | Wells Fargo | Equal Weight |
Alle ansehen
Pulmonx Corp Aktie (LUNG) Neueste Nachrichten
Barclays PLC Sells 27,598 Shares of Pulmonx Co. (NASDAQ:LUNG) - Defense World
Pulmonx Corporation (NASDAQ:LUNG) Q1 2025 Earnings Call Transcript - Insider Monkey
Stifel maintains Buy on Pulmonx stock with $16 target By Investing.com - Investing.com Nigeria
Stifel maintains Buy on Pulmonx stock with $16 target - Investing.com
Canaccord Genuity Group Lowers Pulmonx (NASDAQ:LUNG) Price Target to $15.00 - Defense World
Pulmonx Corp SEC 10-Q Report - TradingView
Pulmonx Corp (NASDAQ: LUNG) Loss Of -10.08% Compared To 52-Week Low; YTD Fall -44.48% – What Should You Do Now? – Marketing Sentinel - Marketing Sentinel
Pulmonx Corp (LUNG) Stock: A Year of Market Movement, Down and Up - investchronicle.com
In the Green: Pulmonx Corp (LUNG) Closes at 3.77, Up/Down -21.95 from Previous Day - DWinneX
Canaccord cuts Pulmonx stock target to $15, maintains Buy rating By Investing.com - Investing.com Nigeria
Pulmonx (LUNG) Price Target Lowered by Canaccord Genuity | LUNG Stock News - GuruFocus
Leading Lung Disease Treatment Pioneer Pulmonx Takes Stage at Bank of America Healthcare Conference - Stock Titan
Pulmonx (LUNG): Analyst Lowers Price Target, Maintains Overweigh - GuruFocus
Pulmonx (LUNG) Maintains "Buy" Rating with Stable Price Target | - GuruFocus
Canaccord cuts Pulmonx stock target to $15, maintains Buy rating - Investing.com
Pulmonx (LUNG) Receives Target Price Adjustment from Canaccord | - GuruFocus
Pulmonx (LUNG) Target Price Adjusted by Piper Sandler Analyst | - GuruFocus
Pulmonx (LUNG) Target Price Adjusted by Piper Sandler Analyst | LUNG Stock News - GuruFocus
Pulmonx Corp (LUNG) Q1 2025 Earnings Call Highlights: Strong International Growth Amid Domestic ... - Yahoo Finance
BlackRock, Inc. Reduces Stake in Pulmonx Corp: Analyzing the Imp - GuruFocus
Earnings call transcript: Pulmonx beats EPS forecast despite revenue miss in Q1 2025 - Investing.com Nigeria
Pulmonx Corp reports results for the quarter ended March 31Earnings Summary - TradingView
Pulmonx earnings beat by $0.03, revenue topped estimates - Investing.com
LUNG Reports Strong Q1 Revenue, Surpasses Expectations | LUNG St - GuruFocus
Pulmonx (LUNG) Reaffirms 2025 Revenue and Expense Projections | - GuruFocus
Pulmonx Corp (LUNG) Q1 2025 Earnings: EPS Loss of $0.36 Beats Es - GuruFocus
Pulmonx (LUNG) Reaffirms 2025 Revenue and Expense Projections | LUNG Stock News - GuruFocus
LUNG Reports Strong Q1 Revenue, Surpasses Expectations | LUNG Stock News - GuruFocus
Pulmonx Co. (NASDAQ:LUNG) Shares Purchased by Renaissance Technologies LLC - Defense World
Geode Capital Management LLC Purchases 9,454 Shares of Pulmonx Co. (NASDAQ:LUNG) - Defense World
Pulmonx Co. (NASDAQ:LUNG) Shares Sold by Russell Investments Group Ltd. - Defense World
Pulmonx Co. (NASDAQ:LUNG) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
Pulmonx stock plunges to 52-week low of $5.38 amid market challenges - Investing.com Nigeria
Vanguard Group Inc. Grows Stock Holdings in Pulmonx Co. (NASDAQ:LUNG) - Defense World
Pulmonx stock plunges to 52-week low, hitting 4.71 USD By Investing.com - Investing.com Canada
Pulmonx stock plunges to 52-week low, hitting 4.71 USD - Investing.com Australia
Leading Lung Treatment Innovator Pulmonx Announces Q1 2025 Earnings Date - Stock Titan
American Century Companies Inc. Grows Stock Position in Pulmonx Co. (NASDAQ:LUNG) - Defense World
151,200 Shares in Pulmonx Co. (NASDAQ:LUNG) Acquired by Norges Bank - Defense World
Analysts Are Bullish on Top Healthcare Stocks: Pacific Biosciences (PACB), Pulmonx (LUNG) - The Globe and Mail
Pulmonx stock plunges to 52-week low of $5.38 amid market challenges By Investing.com - Investing.com South Africa
Charles Schwab Investment Management Inc. Boosts Holdings in Pulmonx Co. (NASDAQ:LUNG) - Defense World
Pulmonx Co. (NASDAQ:LUNG) Receives Consensus Recommendation of “Moderate Buy” from Brokerages - Defense World
Connor Clark & Lunn Investment Management Ltd. Buys 25,988 Shares of Pulmonx Co. (NASDAQ:LUNG) - Defense World
Insider Sell Alert: French Glendon E. III Sells 20,000 Shares of Pulmonx Corp (LUNG) - GuruFocus
Pulmonx corp director Glendon French sells $157,000 in stock By Investing.com - Investing.com Canada
Finanzdaten der Pulmonx Corp-Aktie (LUNG)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.74%
0.94%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):